Acceleron Pharma Inc Revenue Y/Y
What is the Revenue Y/Y of Acceleron Pharma Inc?
The Revenue Y/Y of Acceleron Pharma Inc is 6.39%
What is the definition of Revenue Y/Y?
Yearly revenue growth is the percentage growth of the company’s revenue over trailing twelve months.
= (revenue past four quarters - revenue previous four quarters) / revenue previous four quarters
The yearly revenue growth rate is calculated as the percentage change in revenue over the trailing twelve months. For this specific metric, the calculation takes into account a series of the last eight quarterly revenues. The revenue growth is useful for determining the success of the company expanding its main business. Revenue growth of 5% to 10% is usually considered good for large-cap companies. For other companies, a sales growth of over 10% is more desirable.
Revenue Y/Y of companies in the Health Care sector on NASDAQ compared to Acceleron Pharma Inc
What does Acceleron Pharma Inc do?
Acceleron is a biopharmaceutical company dedicated to the discovery, development, and commercialization of therapeutics to treat serious and rare diseases. Acceleron's leadership in the understanding of TGF-beta superfamily biology and protein engineering generates innovative compounds that engage the body's ability to regulate cellular growth and repair.
Companies with revenue y/y similar to Acceleron Pharma Inc
- Nanogate SE has Revenue Y/Y of 6.37%
- Magna International has Revenue Y/Y of 6.37%
- loanDepot has Revenue Y/Y of 6.38%
- Tesco Plc has Revenue Y/Y of 6.38%
- Dominion Resources has Revenue Y/Y of 6.38%
- Theradiag SA has Revenue Y/Y of 6.38%
- Acceleron Pharma Inc has Revenue Y/Y of 6.39%
- Luceco plc has Revenue Y/Y of 6.39%
- Magna Gold has Revenue Y/Y of 6.39%
- Advanced Micro Devices has Revenue Y/Y of 6.40%
- Universal has Revenue Y/Y of 6.40%
- Hitech has Revenue Y/Y of 6.40%
- AstraZeneca Pharma India has Revenue Y/Y of 6.41%